Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1936 1
1939 2
1940 1
1941 1
1944 1
1945 2
1946 9
1947 5
1948 7
1949 9
1950 6
1951 17
1952 12
1953 19
1954 18
1955 17
1956 11
1957 11
1958 21
1959 17
1960 15
1961 15
1962 17
1963 21
1964 25
1965 18
1966 10
1967 6
1968 13
1969 7
1970 14
1971 21
1972 13
1973 17
1974 18
1975 46
1976 53
1977 57
1978 67
1979 104
1980 115
1981 165
1982 272
1983 328
1984 431
1985 627
1986 832
1987 880
1988 1003
1989 1385
1990 1416
1991 1517
1992 1626
1993 1721
1994 2131
1995 2172
1996 2536
1997 2755
1998 2893
1999 2942
2000 3397
2001 3495
2002 3781
2003 3853
2004 4540
2005 4878
2006 5346
2007 5489
2008 5870
2009 6351
2010 7297
2011 7776
2012 8708
2013 9309
2014 10165
2015 10698
2016 11217
2017 11953
2018 12549
2019 13352
2020 9638
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

170,771 results
Results by year
Filters applied: . Clear all
Page 1
2016 Alzheimer's disease facts and figures.
Alzheimer's Association. Alzheimer's Association. Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001. Alzheimers Dement. 2016. PMID: 27570871
The actual number of deaths to which Alzheimer's disease contributes is likely much larger than the number of deaths from Alzheimer's disease recorded on death certificates. In 2016, an estimated 700,000 Americans age ≥ 65 years will die …
The actual number of deaths to which Alzheimer's disease contributes is likely much larger than the number of deaths fr …
Mouse Models of Alzheimer's Disease.
Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J, Villegas S. Esquerda-Canals G, et al. J Alzheimers Dis. 2017;57(4):1171-1183. doi: 10.3233/JAD-170045. J Alzheimers Dis. 2017. PMID: 28304309 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide and it is predicted to exponentially increase in the coming decades. Because no curative treatment exists, research on the pathophysiology of
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide an
Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
Calsolaro V, Edison P. Calsolaro V, et al. Alzheimers Dement. 2016 Jun;12(6):719-32. doi: 10.1016/j.jalz.2016.02.010. Epub 2016 May 11. Alzheimers Dement. 2016. PMID: 27179961 Review.
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results. It is clear that the "amyloid cascade hypothesis" alone cannot fully explain the neuronal damage in AD, as evidenced both by autopsy an …
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing resu …
Human Gut Microbiota in Health and Alzheimer's Disease.
Szablewski L. Szablewski L. J Alzheimers Dis. 2018;62(2):549-560. doi: 10.3233/JAD-170908. J Alzheimers Dis. 2018. PMID: 29480188 Review.
Gut microbiota plays a crucial role in human health and disease. The alterations in the composition of gut microbiota may cause the onset of certain human pathologies. One of these is Alzheimer's disease (AD). High-fat diets, administration of antibiot …
Gut microbiota plays a crucial role in human health and disease. The alterations in the composition of gut microbiota may cause the o …
Alzheimer's disease: a report from the 7th Kuopio Alzheimer symposium.
Haapasalo A, Pikkarainen M, Soininen H. Haapasalo A, et al. Neurodegener Dis Manag. 2015 Oct;5(5):379-82. doi: 10.2217/nmt.15.31. Epub 2015 Oct 19. Neurodegener Dis Manag. 2015. PMID: 26477468 Free article. Review.
The theme for the symposium in its seventh year was 'From mechanisms to prevention and intervention of Alzheimer's disease'. ...The program, spanning from molecular mechanisms to prevention, prediction, diagnosis and treatment of Alzheimer's
The theme for the symposium in its seventh year was 'From mechanisms to prevention and intervention of Alzheimer's disease
Alzheimer's disease: The next frontier-Special Report 2017.
Karlawish J, Jack CR Jr, Rocca WA, Snyder HM, Carrillo MC. Karlawish J, et al. Alzheimers Dement. 2017 Apr;13(4):374-380. doi: 10.1016/j.jalz.2017.02.006. Epub 2017 Mar 14. Alzheimers Dement. 2017. PMID: 28314660
This has the potential to markedly change how we diagnose Alzheimer's disease and, as a result, how we count the number of people with this disease. As research advances a biomarker-based method for diagnosis and treatment at the earliest stages of …
This has the potential to markedly change how we diagnose Alzheimer's disease and, as a result, how we count the number …
The Mechanisms of Action of Curcumin in Alzheimer's Disease.
Tang M, Taghibiglou C. Tang M, et al. J Alzheimers Dis. 2017;58(4):1003-1016. doi: 10.3233/JAD-170188. J Alzheimers Dis. 2017. PMID: 28527218 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. As the prevalence of AD rises in the 21st century, there is an urgent need for the development of effective pharmacotherapies. Currently, drug treatments target the symptoms of the di
Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. As the prevalence of AD rises in the 21st cent
Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
Khalsa DS. Khalsa DS. J Alzheimers Dis. 2015;48(1):1-12. doi: 10.3233/JAD-142766. J Alzheimers Dis. 2015. PMID: 26445019 Free PMC article. Review.
Mitigating the extensive negative biochemical effects of stress is a superficially discussed target of Alzheimer's disease (AD) prevention, yet may be critically important. This paper reviews lifestyle and stress as possible factors contributing to AD and med …
Mitigating the extensive negative biochemical effects of stress is a superficially discussed target of Alzheimer's disease
Neuropsychiatric symptoms in Alzheimer's disease.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Lyketsos CG, et al. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease and …
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge …
Female Sex and Alzheimer's Risk: The Menopause Connection.
Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, Diaz Brinton R, Mosconi L. Scheyer O, et al. J Prev Alzheimers Dis. 2018;5(4):225-230. doi: 10.14283/jpad.2018.34. J Prev Alzheimers Dis. 2018. PMID: 30298180 Free PMC article. Review.
Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer's disease (AD). ...
Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer
170,771 results
Jump to page
Feedback